This inventor holds 1 USPTO granted patent and 1 published patent application, plus 4 CIPO patents and 1 EPO patent. Top assignee: Ketogen Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Paula J Estey: Innovator in CNS Disorder Treatments
Introduction
Paula J Estey is a notable inventor based in Neebing, Canada. She has made significant contributions to the field of medicine, particularly in the treatment of central nervous system (CNS) disorders. Her innovative work focuses on developing compounds that can aid in the treatment of seizures and other related conditions.
Latest Patents
Estey holds a patent for "Compounds for the treatment of seizures and other central nervous systems disorders and conditions." This patent relates to novel compounds that lead to the metabolic production of ketones, which are bonded to a ketone-potentiated anti-epileptic drug. The compositions derived from these compounds are intended for the treatment of epilepsy and other CNS diseases, disorders, or conditions. Specifically, the patent includes compounds of Formula I, along with their compositions and uses.
Career Highlights
Throughout her career, Estey has demonstrated a commitment to advancing medical science through her innovative research. Her work at Ketogen Inc. has positioned her as a key player in the development of new therapeutic options for patients suffering from CNS disorders.
Collaborations
Estey has collaborated with notable professionals in her field, including Norton W Milgram and Jaipal Reddy Nagireddy. These collaborations have further enhanced her research and contributed to the success of her innovative projects.
Conclusion
Paula J Estey's contributions to the treatment of CNS disorders through her patented compounds highlight her role as a pioneering inventor. Her work continues to impact the medical field positively, offering hope for improved treatments for those affected by seizures and other CNS conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile